MiRNA-based therapy for Pulmonary Hypertension: MiRNA-302b inhibits pulmonary hypertension via down regulation of its target genes, 21/January/2015, 19.05

Molecular therapy for Hypertension: Gastrin decreases arterial blood pressure and vascular remodelling via up regulation of its target gene, 21/January/2014, 13.11
January 21, 2015
MiRNA-based therapy for pulmonary arterial hypertension: MiRNA-28 inhibits the development of pulmonary arterial hypertension via down regulation of its target gene, 21/January/2014, 19.27
January 21, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, MiRNA-based therapy for Pulmonary Hypertension: MiRNA-302b inhibits pulmonary hypertension via down regulation of its target genes, 21/January/2015, 19.05, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that MiRNA-302b, by increasing the expression of its target genes, it may inhibit pulmonary hypertension. Thus, pharmacological formulations encompassing “MiRNA-302b or its activators”  may be used to treat pulmonary hypertension.

Amount: $ 300

Undisclosed information: How MiRNA-302b inhibits the development of pulmonary hypertension

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.